Madrigal Pharmaceuticals, Inc. (MDGL) Balance Sheet
As of 2026-06-30 (10-Q), Madrigal Pharmaceuticals, Inc. (MDGL) reported total assets of $1.2B, total liabilities of $720.9M and shareholders' equity of $523.7M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $292.7M. Long-term debt: $340.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MDGLMadrigal Pharmaceuticals, Inc.Follow MDGL — free
—
Price chart with a free account
- Market cap
- 10.0B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.03 | 0.08 | 0.05 | 0.00 | 0.00 | 0.02 | 0.15 | 0.06 | 0.05 | 0.05 | 0.04 | 0.33 | 0.10 | 0.10 | 0.20 | 0.29 | |
| Short-term investments | 0.01 | 0.02 | 0.04 | 0.05 | 0.03 | 0.02 | 0.04 | 0.43 | 0.39 | 0.23 | 0.23 | 0.03 | 0.53 | 0.83 | 0.78 | 0.55 | |
| Receivables | — | — | — | — | — | — | — | — | — | — | — | — | 0.00 | 0.05 | 0.13 | 0.19 | |
| Inventory | — | — | — | — | — | — | — | — | — | — | — | — | 0.00 | 0.03 | 0.07 | 0.10 | |
| Current assets | 0.04 | 0.10 | 0.09 | 0.10 | 0.00 | 0.04 | 0.19 | 0.49 | 0.44 | 0.29 | 0.27 | 0.36 | 0.64 | 1.03 | 1.25 | 1.20 | |
| Total assets | 0.04 | 0.10 | 0.10 | 0.10 | 0.00 | 0.04 | 0.19 | 0.49 | 0.44 | 0.29 | 0.27 | 0.36 | 0.64 | 1.04 | 1.26 | 1.24 | |
| Current liabilities | 0.02 | 0.02 | 0.03 | 0.03 | 0.05 | 0.00 | 0.01 | 0.01 | 0.03 | 0.05 | 0.08 | 0.12 | 0.12 | 0.17 | 0.31 | 0.37 | |
| Long-term debt | — | — | 0.02 | 0.01 | — | — | — | — | — | — | 0.00 | 0.05 | 0.12 | 0.12 | 0.34 | 0.34 | |
| Total liabilities | 0.03 | 0.03 | 0.05 | 0.04 | 0.05 | 0.00 | 0.01 | 0.01 | 0.03 | 0.05 | 0.08 | 0.17 | 0.24 | 0.29 | 0.66 | 0.72 | |
| Shareholders' equity | 0.01 | 0.08 | 0.05 | -0.04 | -0.05 | 0.04 | 0.18 | 0.48 | 0.42 | 0.24 | 0.20 | 0.20 | 0.41 | 0.75 | 0.60 | 0.52 |
USD billions · SEC XBRL
Madrigal Pharmaceuticals, Inc. — questions
- How much cash does Madrigal Pharmaceuticals, Inc. have?
- $292.7M in cash and cash equivalents as of 2026-06-30.
- How much debt does Madrigal Pharmaceuticals, Inc. have?
- $340.8M of long-term debt as of 2026-06-30.
- What are Madrigal Pharmaceuticals, Inc.'s total assets?
- $1.2B as of 2026-06-30.
- What is Madrigal Pharmaceuticals, Inc.'s shareholders' equity?
- $523.7M as of 2026-06-30.
Every figure on this page comes from Madrigal Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.